Export Administration Regulations compliance
Export Administration Regulations compliance in Healthcare & Life Sciences is more operationally complex than most compliance teams budget for. The U.S. Department of Commerce Bureau of Industry and Security administers the EAR controls that govern biological materials, diagnostic equipment, and certain software exports, and its intersection with sector-specific oversight from the U.S. Food and Drug Administration creates dual-authority exposure that catches exporters off guard. Life sciences firms shipping controlled items to China, Russia, or sanctioned-adjacent distributors are rebuilding their end-user screening workflows now, not after the next enforcement action.
Watch
- BIS Entity List additions affecting biotech reagent and lab instrument suppliers
- EAR99 reclassification risk for AI-enabled diagnostic software under ECCN 4E001
- De minimis rule thresholds as applied to foreign-manufactured medical device components
- Commerce Department proposed rules on foundational biosecurity export controls, comment period status
Recent material activity in Healthcare & Life Sciences
Active monitoring in place across Healthcare & Life Sciences. Material developments related to export administration regulations compliance will appear here as they are published.